4.7 Article

Peptide hormone ELABELA promotes rat bone marrow-derived mesenchymal stem cell proliferation and migration by manipulating the cell cycle through the PI3K/AKT pathway under the hypoxia and ischemia microenvironmemt

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cardiac & Cardiovascular Systems

The Elabela-APJ axis: a promising therapeutic target for heart failure

Zheng Ma et al.

Summary: The ELA-APJ axis plays a crucial role in cardiovascular protection, with various physiological effects that can be used to treat hypertension, myocardial infarction, and HF, potentially providing a new therapeutic approach for HF.

HEART FAILURE REVIEWS (2021)

Article Developmental Biology

ELABELA alleviates syncytiotrophoblast hypoxia/reoxygenation injury and preeclampsia-like symptoms in mice by reducing apoptosis

Jing Ma et al.

Summary: ELABELA was found to have decreased expression in severe preeclampsia, while promoting trophoblast proliferation. It also showed potential in improving symptoms in a preeclampsia mouse model.

PLACENTA (2021)

Article Cell & Tissue Engineering

Lineage Commitment, Signaling Pathways, and the Cytoskeleton Systems in Mesenchymal Stem Cells

Aleena A. Saidova et al.

TISSUE ENGINEERING PART B-REVIEWS (2020)

Review Cardiac & Cardiovascular Systems

Stem Cell Therapy for Acute Myocardial Infarctions A Systematic Review

Joseph Rudman et al.

CARDIOLOGY IN REVIEW (2020)

Review Pharmacology & Pharmacy

Systemic and local delivery of mesenchymal stem cells for heart renovation: Challenges and innovations

Ziwei Liu et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2020)

Review Oncology

Apelin/Elabela-APJ: a novel therapeutic target in the cardiovascular system

Wei Liu et al.

ANNALS OF TRANSLATIONAL MEDICINE (2020)

Article Pharmacology & Pharmacy

ELABELA improves endothelial cell functionviathe ELA-APJ axis by activating the PI3K/Akt signalling pathway in HUVECs and EA.hy926 cells

Xiujuan Wang et al.

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2020)

Article Pharmacology & Pharmacy

Mesenchymal Stem Cells in Cardiac Repair: Effects on Myocytes, Vasculature, and Fibroblasts

Samuel J. White et al.

CLINICAL THERAPEUTICS (2020)

Review Cell Biology

Putting the brakes on the cell cycle: mechanisms of cellular growth arrest

Lindsey R. Pack et al.

CURRENT OPINION IN CELL BIOLOGY (2019)

Article Medicine, Research & Experimental

Modulation of autophagy as new approach in mesenchymal stem cell-based therapy

Jelena Jakovljevic et al.

BIOMEDICINE & PHARMACOTHERAPY (2018)

Review Cell Biology

Biological functions of Elabela, a novel endogenous ligand of APJ receptor

Jin Xu et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2018)

Review Cell & Tissue Engineering

Cardiomyocyte differentiation of mesenchymal stem cells from bone marrow: new regulators and its implications

Xiaofei Guo et al.

STEM CELL RESEARCH & THERAPY (2018)

Review Cell & Tissue Engineering

Gene Delivery Approaches for Mesenchymal Stem Cell Therapy: Strategies to Increase Efficiency and Specificity

Gopi Suresh Oggu et al.

STEM CELL REVIEWS AND REPORTS (2017)

Review Cell & Tissue Engineering

A brief review: the therapeutic potential of bone marrow mesenchymal stem cells in myocardial infarction

Chi Miao et al.

STEM CELL RESEARCH & THERAPY (2017)

Review Cell & Tissue Engineering

Gene Delivery Approaches for Mesenchymal Stem Cell Therapy: Strategies to Increase Efficiency and Specificity

Gopi Suresh Oggu et al.

STEM CELL REVIEWS AND REPORTS (2017)

Article Cardiac & Cardiovascular Systems

ELABELA-APJ axis protects from pressure overload heart failure and angiotensin II-induced cardiac damage

Teruki Sato et al.

CARDIOVASCULAR RESEARCH (2017)

Article Cell Biology

ELABELA: A Hormone Essential for Heart Development Signals via the Apelin Receptor

Serene C. Chng et al.

DEVELOPMENTAL CELL (2013)

Review Cell & Tissue Engineering

Harnessing the Mesenchymal Stem Cell Secretome for the Treatment of Cardiovascular Disease

Sudhir H. Ranganath et al.

CELL STEM CELL (2012)